
Pharma
Astrana Health Credits AI-Native Platform as Q2 Revenue Climbs 49%
Astrana Health raised its 2026 EBITDA outlook after reporting strong second-quarter growth driven by its AI-native healthcare platform.
PharmaCompany

Astrana Health reported a 49% increase in Q2 revenue, attributing the growth to its AI-native healthcare platform. The company also raised its EBITDA outlook for 2026 following this strong performance.
+0 in the last 30 days
Latest: Aug 6, 2026
Latest tracker entry
49% quarterly revenue growth
healthcare




MachineCon USA · from AIM Media House
An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.



